Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression
BackgroundAccumulating studies suggested that major depressive disorder (MDD) was closely related to metabolic syndrome (MetS). Important endogenous regulators fibroblast growth factors (FGFs) 19 and 21 were also reported to participate in psychiatric disorders. This study aimed to investigate the r...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-05-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2023.1165443/full |
| _version_ | 1797825562882867200 |
|---|---|
| author | Mimi Tang Mimi Tang Shuqiao Cheng Shuqiao Cheng Lu Wang Hui Tang Ting Liu Ting Liu Tingyu Zhao Tingyu Zhao Ruili Dang |
| author_facet | Mimi Tang Mimi Tang Shuqiao Cheng Shuqiao Cheng Lu Wang Hui Tang Ting Liu Ting Liu Tingyu Zhao Tingyu Zhao Ruili Dang |
| author_sort | Mimi Tang |
| collection | DOAJ |
| description | BackgroundAccumulating studies suggested that major depressive disorder (MDD) was closely related to metabolic syndrome (MetS). Important endogenous regulators fibroblast growth factors (FGFs) 19 and 21 were also reported to participate in psychiatric disorders. This study aimed to investigate the role of FGF19 and FGF21 in MDD and to explore the possible pathogenic mechanism of metabolic and cognitive dysregulation in depression.MethodsA total of 59 MDD patients and 55 healthy control participants were recruited. The serum levels of FGF19 and FGF21 and lipid profiles were measured by means of enzymatic methods. Cognitive function was measured by repeatable battery for the assessment of neuropsychological status (RBANS) scores. The gene expression of PGC-1α and FNDC5 was determined by quantitative polymerase chain reaction (PCR).ResultsWe found that plasma FGF19 and FGF21 levels were significantly decreased in patients with MDD. Meanwhile, triglyceride (TG) was significantly elevated and PGC-1α was significantly downregulated in MDD patients. Correlation analyses showed negative associations between TG and FGF19 levels. As for cognitive performance, both FGF19 and FGF21 levels were positively correlated with immediate memory. However, FGF19 levels were negatively correlated with language, and FGF21 levels were also negatively correlated with attention and delayed memory. Additionally, negative associations were found between FGF19 levels and PGC-1α. FGF21 levels were positively associated with PGC-1α and negatively associated with FNDC5.ConclusionThis study elucidated the role of FGF19 and FGF21 in MDD. MDD patients were confirmed to have metabolic and cognitive dysregulation, and this abnormality was linked to the decreased concentrations of FGF19 and FGF21 through the PGC-1α/FNDC5 pathway. Our results showed that the alterations of FGF19 and FGF21 levels may be a common pathogenic mechanism of metabolic and cognitive disturbances in patients with MDD. |
| first_indexed | 2024-03-13T10:55:47Z |
| format | Article |
| id | doaj.art-e319916735d34b5cb1b8a2f7ece8ff24 |
| institution | Directory Open Access Journal |
| issn | 1662-453X |
| language | English |
| last_indexed | 2024-03-13T10:55:47Z |
| publishDate | 2023-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neuroscience |
| spelling | doaj.art-e319916735d34b5cb1b8a2f7ece8ff242023-05-17T04:47:19ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2023-05-011710.3389/fnins.2023.11654431165443Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depressionMimi Tang0Mimi Tang1Shuqiao Cheng2Shuqiao Cheng3Lu Wang4Hui Tang5Ting Liu6Ting Liu7Tingyu Zhao8Tingyu Zhao9Ruili Dang10Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, ChinaInstitute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, ChinaInstitute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaMental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, ChinaMental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, ChinaInstitute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, ChinaInstitute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaTranslational Pharmaceutical Laboratory, Jining First People’s Hospital, Jining Medical University, Jining, ChinaBackgroundAccumulating studies suggested that major depressive disorder (MDD) was closely related to metabolic syndrome (MetS). Important endogenous regulators fibroblast growth factors (FGFs) 19 and 21 were also reported to participate in psychiatric disorders. This study aimed to investigate the role of FGF19 and FGF21 in MDD and to explore the possible pathogenic mechanism of metabolic and cognitive dysregulation in depression.MethodsA total of 59 MDD patients and 55 healthy control participants were recruited. The serum levels of FGF19 and FGF21 and lipid profiles were measured by means of enzymatic methods. Cognitive function was measured by repeatable battery for the assessment of neuropsychological status (RBANS) scores. The gene expression of PGC-1α and FNDC5 was determined by quantitative polymerase chain reaction (PCR).ResultsWe found that plasma FGF19 and FGF21 levels were significantly decreased in patients with MDD. Meanwhile, triglyceride (TG) was significantly elevated and PGC-1α was significantly downregulated in MDD patients. Correlation analyses showed negative associations between TG and FGF19 levels. As for cognitive performance, both FGF19 and FGF21 levels were positively correlated with immediate memory. However, FGF19 levels were negatively correlated with language, and FGF21 levels were also negatively correlated with attention and delayed memory. Additionally, negative associations were found between FGF19 levels and PGC-1α. FGF21 levels were positively associated with PGC-1α and negatively associated with FNDC5.ConclusionThis study elucidated the role of FGF19 and FGF21 in MDD. MDD patients were confirmed to have metabolic and cognitive dysregulation, and this abnormality was linked to the decreased concentrations of FGF19 and FGF21 through the PGC-1α/FNDC5 pathway. Our results showed that the alterations of FGF19 and FGF21 levels may be a common pathogenic mechanism of metabolic and cognitive disturbances in patients with MDD.https://www.frontiersin.org/articles/10.3389/fnins.2023.1165443/fullFGF19FGF21metabolic dysregulationcognitive dysregulationdepression |
| spellingShingle | Mimi Tang Mimi Tang Shuqiao Cheng Shuqiao Cheng Lu Wang Hui Tang Ting Liu Ting Liu Tingyu Zhao Tingyu Zhao Ruili Dang Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression Frontiers in Neuroscience FGF19 FGF21 metabolic dysregulation cognitive dysregulation depression |
| title | Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression |
| title_full | Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression |
| title_fullStr | Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression |
| title_full_unstemmed | Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression |
| title_short | Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression |
| title_sort | decreased fgf19 and fgf21 possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression |
| topic | FGF19 FGF21 metabolic dysregulation cognitive dysregulation depression |
| url | https://www.frontiersin.org/articles/10.3389/fnins.2023.1165443/full |
| work_keys_str_mv | AT mimitang decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT mimitang decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT shuqiaocheng decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT shuqiaocheng decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT luwang decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT huitang decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT tingliu decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT tingliu decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT tingyuzhao decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT tingyuzhao decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression AT ruilidang decreasedfgf19andfgf21possibleunderlyingcommonpathogenicmechanismofmetabolicandcognitivedysregulationindepression |